Concepedia

Andrea Ivans

AI

Statistics

Publications

2

Citations

26

H-Index

2

Active since

2021

Affiliations

Biohaven Pharmaceuticals (United States)(Current)

Certara (United States)

Integra LifeSciences (United States)

Andrea Ivans is an author at Biohaven Pharmaceuticals (United States) specializing in medicine, drug safety, and clinical pharmacology.

Top concepts

Publications per year

2021–2023

2

Publications

2

A phase 1 randomized study of hemodynamic effects and pharmacokinetic interactions during concomitant use of rimegepant and sumatriptan in healthy adults

Robert Croop, Andrea Ivans, Matt S. Anderson et al. · Cephalalgia Reports · 2021 · 16 citations · Full text

, , +18

Rimegepant 75 mg in Subjects With Hepatic Impairment: Results of a Phase 1, Open‐Label, Single‐Dose, Parallel‐Group Study

Rajinder Bhardwaj, Andrea Ivans, Joseph Stringfellow et al. · Clinical Pharmacology in Drug Development · 2023 · 10 citations · Full text

1–2 of 2